Uncharacterized Protein, Uncharacterized
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 10 |
| NetGPI | no | yes: 0, no: 10 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 10 |
| GO:0110165 | cellular anatomical entity | 1 | 10 |
Related structures:
AlphaFold database: A0A3S7X4X5
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 126 | 128 | PF00675 | 0.479 |
| CLV_PCSK_KEX2_1 | 126 | 128 | PF00082 | 0.508 |
| CLV_PCSK_KEX2_1 | 92 | 94 | PF00082 | 0.621 |
| CLV_PCSK_PC1ET2_1 | 92 | 94 | PF00082 | 0.641 |
| CLV_PCSK_SKI1_1 | 115 | 119 | PF00082 | 0.409 |
| DOC_CDC14_PxL_1 | 11 | 19 | PF14671 | 0.447 |
| DOC_MAPK_gen_1 | 77 | 85 | PF00069 | 0.391 |
| DOC_MAPK_gen_1 | 92 | 102 | PF00069 | 0.340 |
| DOC_MAPK_MEF2A_6 | 79 | 87 | PF00069 | 0.387 |
| DOC_MAPK_MEF2A_6 | 95 | 104 | PF00069 | 0.402 |
| DOC_MAPK_RevD_3 | 100 | 115 | PF00069 | 0.362 |
| DOC_USP7_UBL2_3 | 73 | 77 | PF12436 | 0.445 |
| LIG_14-3-3_CanoR_1 | 28 | 33 | PF00244 | 0.688 |
| LIG_14-3-3_CanoR_1 | 79 | 87 | PF00244 | 0.475 |
| LIG_BRCT_BRCA1_1 | 59 | 63 | PF00533 | 0.447 |
| LIG_FHA_1 | 16 | 22 | PF00498 | 0.424 |
| LIG_FHA_1 | 36 | 42 | PF00498 | 0.623 |
| LIG_LIR_Gen_1 | 3 | 12 | PF02991 | 0.446 |
| LIG_LIR_Gen_1 | 59 | 68 | PF02991 | 0.379 |
| LIG_LIR_Nem_3 | 18 | 23 | PF02991 | 0.495 |
| LIG_LIR_Nem_3 | 3 | 7 | PF02991 | 0.439 |
| LIG_LIR_Nem_3 | 59 | 64 | PF02991 | 0.341 |
| LIG_PCNA_PIPBox_1 | 13 | 22 | PF02747 | 0.402 |
| LIG_Pex14_1 | 70 | 74 | PF04695 | 0.362 |
| LIG_Pex14_2 | 61 | 65 | PF04695 | 0.384 |
| LIG_SH2_CRK | 23 | 27 | PF00017 | 0.480 |
| LIG_SH2_PTP2 | 101 | 104 | PF00017 | 0.362 |
| LIG_SH2_STAT5 | 101 | 104 | PF00017 | 0.282 |
| LIG_SH2_STAT5 | 23 | 26 | PF00017 | 0.484 |
| LIG_SH3_3 | 9 | 15 | PF00018 | 0.447 |
| LIG_UBA3_1 | 64 | 73 | PF00899 | 0.540 |
| LIG_WRC_WIRS_1 | 1 | 6 | PF05994 | 0.515 |
| LIG_WRC_WIRS_1 | 58 | 63 | PF05994 | 0.381 |
| MOD_CK1_1 | 59 | 65 | PF00069 | 0.435 |
| MOD_GlcNHglycan | 128 | 132 | PF01048 | 0.486 |
| MOD_GlcNHglycan | 52 | 55 | PF01048 | 0.456 |
| MOD_NEK2_2 | 15 | 20 | PF00069 | 0.480 |
| MOD_PK_1 | 28 | 34 | PF00069 | 0.529 |
| MOD_PKA_2 | 35 | 41 | PF00069 | 0.633 |
| MOD_PKA_2 | 78 | 84 | PF00069 | 0.473 |
| MOD_Plk_1 | 81 | 87 | PF00069 | 0.385 |
| MOD_Plk_4 | 115 | 121 | PF00069 | 0.379 |
| MOD_Plk_4 | 15 | 21 | PF00069 | 0.426 |
| MOD_Plk_4 | 47 | 53 | PF00069 | 0.325 |
| MOD_SUMO_rev_2 | 84 | 94 | PF00179 | 0.440 |
| TRG_ENDOCYTIC_2 | 101 | 104 | PF00928 | 0.343 |
| TRG_ER_diArg_1 | 125 | 127 | PF00400 | 0.722 |
| TRG_ER_diArg_1 | 93 | 96 | PF00400 | 0.410 |
| TRG_NLS_MonoExtC_3 | 91 | 97 | PF00514 | 0.352 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P4A6 | Leptomonas seymouri | 70% | 99% |
| A0A0S4IVS1 | Bodo saltans | 26% | 90% |
| A0A1X0NIN7 | Trypanosomatidae | 37% | 100% |
| A0A3R7L4C4 | Trypanosoma rangeli | 33% | 87% |
| A4HJQ9 | Leishmania braziliensis | 84% | 100% |
| A4I776 | Leishmania infantum | 100% | 100% |
| C9ZMF7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 34% | 100% |
| E9B270 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |
| Q4Q5Y9 | Leishmania major | 95% | 100% |